According to BioIntel360, United Kingdom diabetes devices market size is expected to record a CAGR of 9.9% during 2023-2027 to reach US$10,793.2 million by 2027, increasing from US$6,731.1 million in...
According to BioIntel360, United Kingdom diabetes devices market size is expected to record a CAGR of 9.9% during 2023-2027 to reach US$10,793.2 million by 2027, increasing from US$6,731.1 million in 2023. Over the last five years, the sector has recorded a CAGR of 11.1% to reach US$6,057.4 million in 2022. This report provides an in-depth data-centric analysis of the emerging opportunities in the diabetes devices and therapeutics industry. It covers a detailed view of market size and forecast across various segments such as by category, diagnosis and monitoring devices, therapeutics, route of administration, type of diabetes, distribution channels, and end users. This section is a part of the title “Global Diabetes Devices and Therapeutics Business and Investment Opportunities – Analysis & Market Size by Technology, Clinical Trials, Patents, Financial Deals, and Competitive Landscape – Q2 2023 Update”.
This report provides an in-depth, data-centric analysis of the United Kingdom diabetes devices and therapeutics market 2018-2027. Below is a summary of key market segments: Diabetes Devices and Therapeutics Market Share by Category • Diagnosis and Monitoring Devices • Therapeutics Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices • Blood Glucose Monitoring Devices • Insulin Delivery Devices • Diabetes Management and Mobile Applications • Artificial Pancreas Devices Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices • Self-Monitoring Blood Glucose Devices • Continuous Blood Glucose Monitoring Devices • Test Strips • Lancets Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices • Insulin Pumps • Insulin Pens • Insulin Syringes Diabetes Devices and Therapeutics Market Share by Therapeutics • Oral Anti-Diabetic Drugs • Insulin • Non-Insulin Injectable Drugs • Combination Drugs Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs • Alpha-Glucosidase Inhibitors • DPP-4 Inhibitors • SGLT-2 Inhibitors Diabetes Devices and Therapeutics Market Share by Insulin • Basal or Long-Acting • Bolus or Fast-Acting • Traditional Human Insulin Drugs • Insulin Biosimilars Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs • GLP-1 Receptor Agonists • Amylin Analogue Diabetes Devices and Therapeutics Market Share by Combination Drugs • Combination Insulin • Oral Combination Diabetes Devices and Therapeutics Market Share by Route of Administration • Subcutaneous • Intravenous • Others Diabetes Devices and Therapeutics Market Share by Type of Diabetes • Type 1 Diabetes • Type 2 Diabetes Diabetes Devices and Therapeutics Market Share by Distribution Channels • Online Pharmacies • Hospital Pharmacies • Retail Pharmacies Diabetes Devices and Therapeutics Market Share by End User • Hospitals • Diabetes Clinics • Homecare
• In-depth understanding of diabetes devices and therapeutics market dynamics: Understand market opportunity, industry dynamics, key trends, and drivers across different market segments and sub-segments of the industry in United Kingdom. • Develop market-specific strategies: Identify growth segments and target specific opportunities to formulate your investment strategy; assess market-specific key trends, drivers, and risks in the industry. • Get market share analysis by end users: Get a detailed analysis across different end users such as hospitals, diabetes clinics, and homecare within the United Kingdom.
1 United Kingdom Diabetes Devices and Therapeutics Market Size and Forecast, 2018-2027 2 United Kingdom Diabetes Devices and Therapeutics Market Share by Category, 2018-2027 2.1 United Kingdom Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, 2018-2027 2.2 United Kingdom Diabetes Devices and Therapeutics Market Size by Therapeutics, 2018-2027 3 United Kingdom Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices, 2018-2027 3.1 Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, 2018-2027 3.2 Diabetes Devices and Therapeutics Market Size by Insulin Delivery Devices, 2018-2027 3.3 Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, 2018-2027 3.4 Diabetes Devices and Therapeutics Market Size by Artificial Pancreas Devices, 2018-2027 4 United Kingdom Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices, 2018-2027 4.1 Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, 2018-2027 4.2 Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, 2018-2027 4.3 Diabetes Devices and Therapeutics Market Size by Test Strips, 2018-2027 4.4 Diabetes Devices and Therapeutics Market Size by Lancets, 2018-2027 5 United Kingdom Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices, 2018-2027 5.1 Diabetes Devices and Therapeutics Market Size by Insulin Pumps, 2018-2027 5.2 Diabetes Devices and Therapeutics Market Size by Insulin Pens, 2018-2027 5.3 Diabetes Devices and Therapeutics Market Size by Insulin Syringes, 2018-2027 6 United Kingdom Diabetes Devices and Therapeutics Market Share by Therapeutics, 2018-2027 6.1 Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, 2018-2027 6.2 Diabetes Devices and Therapeutics Market Size by Insulin, 2018-2027 6.3 Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, 2018-2027 6.4 Diabetes Devices and Therapeutics Market Size by Combination Drugs, 2018-2027 7 United Kingdom Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs, 2018-2027 7.1 Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors, 2018-2027 7.2 Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors, 2018-2027 7.3 Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors, 2018-2027 8 United Kingdom Diabetes Devices and Therapeutics Market Share by Insulin, 2018-2027 8.1 Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, 2018-2027 8.2 Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, 2018-2027 8.3 Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, 2018-2027 8.4 Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, 2018-2027 9 United Kingdom Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs, 2018-2027 9.1 Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, 2018-2027 9.2 Diabetes Devices and Therapeutics Market Size by Amylin Analogue, 2018-2027 10 United Kingdom Diabetes Devices and Therapeutics Market Share by Combination Drugs, 2018-2027 10.1 Diabetes Devices and Therapeutics Market Size by Combination Insulin, 2018-2027 10.2 Diabetes Devices and Therapeutics Market Size by Oral Combination, 2018-2027 11 United Kingdom Diabetes Devices and Therapeutics Market Share by Route of Administration, 2018-2027 11.1 Diabetes Devices and Therapeutics Market Size by Subcutaneous, 2018-2027 11.2 Diabetes Devices and Therapeutics Market Size by Intravenous, 2018-2027 11.3 Diabetes Devices and Therapeutics Market Size by Others, 2018-2027 12 United Kingdom Diabetes Devices and Therapeutics Market Share by Type of Diabetes, 2018-2027 12.1 Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, 2018-2027 12.2 Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, 2018-2027 13 United Kingdom Diabetes Devices and Therapeutics Market Share by Distribution Channels, 2018-2027 13.1 Diabetes Devices and Therapeutics Market Size by Online Pharmacies, 2018-2027 13.2 Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, 2018-2027 13.3 Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, 2018-2027 14 United Kingdom Diabetes Devices and Therapeutics Market Share by End User, 2018-2027 14.1 Diabetes Devices and Therapeutics Market Size by Hospitals, 2018-2027 14.2 Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, 2018-2027 14.3 Diabetes Devices and Therapeutics Market Size by Homecare, 2018-2027
Table 1: United Kingdom Diabetes Devices and Therapeutics Market Size by Value (USD MM) 2018-2027 Table 2: United Kingdom Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, by Value (USD MM), 2018-2027 Table 3: United Kingdom Diabetes Devices and Therapeutics Market Size by Therapeutics, by Value (USD MM) 2018-2027 Table 4: United Kingdom Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, by Value (USD MM) 2018-2027 Table 5: United Kingdom Diabetes Devices and Therapeutics Market Size by Insulin Delivery Devices, by Value (USD MM) 2018-2027 Table 6: United Kingdom Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, by Value (USD MM) 2018-2027 Table 7: United Kingdom Diabetes Devices and Therapeutics Market Size by Artificial Pancreas Devices, by Value (USD MM) 2018-2027 Table 8: United Kingdom Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, by Value (USD MM) 2018-2027 Table 9: United Kingdom Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, by Value (USD MM) 2018-2027 Table 10: United Kingdom Diabetes Devices and Therapeutics Market Size by Test Strips, by Value (USD MM) 2018-2027 Table 11: United Kingdom Diabetes Devices and Therapeutics Market Size by Lancets, by Value (USD MM) 2018-2027 Table 12: United Kingdom Diabetes Devices and Therapeutics Market Size by Insulin Pumps, by Value (UDS MM) 2018-2027 Table 13: United Kingdom Diabetes Devices and Therapeutics Market Size by Insulin Pens, by Value (UDS MM) 2018-2027 Table 14: United Kingdom Diabetes Devices and Therapeutics Market Size by Insulin Syringes, by Value (UDS MM) 2018-2027 Table 15: United Kingdom Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, by Value (USD MM), 2018-2027 Table 16: United Kingdom Diabetes Devices and Therapeutics Market Size by Insulin, by Value (USD MM), 2018-2027 Table 17: United Kingdom Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, by Value (USD MM), 2018-2027 Table 18: United Kingdom Diabetes Devices and Therapeutics Market Size by Combination Drugs, by Value (USD MM), 2018-2027 Table 19: United Kingdom Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors (USD MM), 2018-2027 Table 20: United Kingdom Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors (USD MM), 2018-2027 Table 21: United Kingdom Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors (USD MM), 2018-2027 Table 22: United Kingdom Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, by Value (USD MM), 2018-2027 Table 23: United Kingdom Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, by Value (USD MM), 2018-2027 Table 24: United Kingdom Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, by Value (USD MM), 2018-2027 Table 25: United Kingdom Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, by Value (USD MM), 2018-2027 Table 26: United Kingdom Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, by Value (USD MM), 2018-2027 Table 27: United Kingdom Diabetes Devices and Therapeutics Market Size by Amylin Analogue, by Value (USD MM), 2018-2027 Table 28: United Kingdom Diabetes Devices and Therapeutics Market Size by Combination Insulin, by Value (USD MM), 2018-2027 Table 29: United Kingdom Diabetes Devices and Therapeutics Market Size by Oral Combination, by Value (USD MM), 2018-2027 Table 30: United Kingdom Diabetes Devices and Therapeutics Market Size by Subcutaneous, by Value (USD MM), 2018-2027 Table 31: United Kingdom Diabetes Devices and Therapeutics Market Size by Intravenous, by Value (USD MM), 2018-2027 Table 32: United Kingdom Diabetes Devices and Therapeutics Market Size by Others, by Value (USD MM), 2018-2027 Table 33: United Kingdom Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, by Value (USD MM), 2018-2027 Table 34: United Kingdom Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, by Value (USD MM), 2018-2027 Table 35: United Kingdom Diabetes Devices and Therapeutics Market Size by Online Pharmacies, by Value (USD MM), 2018-2027 Table 36: United Kingdom Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, by Value (USD MM), 2018-2027 Table 37: United Kingdom Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, by Value (USD MM), 2018-2027 Table 38: United Kingdom Diabetes Devices and Therapeutics Market Size by Hospitals, by Value (USD MM), 2018-2027 Table 39: United Kingdom Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, by Value (USD MM), 2018-2027 Table 40: United Kingdom Diabetes Devices and Therapeutics Market Size by Homecare, by Value (USD MM), 2018-2027
Figure 1: United Kingdom Diabetes Devices and Therapeutics Market Size by Value (USD MM) 2018-2027 Figure 2: United Kingdom Diabetes Devices and Therapeutics Market Share by Category (%), 2018-2027 Figure 3: United Kingdom Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, by Value (USD MM), 2018-2027 Figure 4: United Kingdom Diabetes Devices and Therapeutics Market Size by Therapeutics, by Value (USD MM) 2018-2027 Figure 5: United Kingdom Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices (%), 2018-2027 Figure 6: United Kingdom Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, by Value (USD MM) 2018-2027 Figure 7: United Kingdom Diabetes Devices and Therapeutics Market Size, by Insulin Delivery Devices, by Value (USD MM) 2018-2027 Figure 8: United Kingdom Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, by Value (USD MM) 2018-2027 Figure 9: United Kingdom Diabetes Devices and Therapeutics Market Size, by Artificial Pancreas Devices, by Value (USD MM) 2018-2027 Figure 10: United Kingdom Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices (%), 2018-2027 Figure 11: United Kingdom Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, by Value (USD MM) 2018-2027 Figure 12: United Kingdom Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, by Value (USD MM) 2018-2027 Figure 13: United Kingdom Diabetes Devices and Therapeutics Market Size by Test Strips, by Value (USD MM) 2018-2027 Figure 14: United Kingdom Diabetes Devices and Therapeutics Market Size by Lancets, by Value (USD MM) 2018-2027 Figure 15: United Kingdom Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices (%), 2018-2027 Figure 16: United Kingdom Diabetes Devices and Therapeutics Market Share by Insulin Pumps, by Value (UDS MM) 2018-2027 Figure 17: United Kingdom Diabetes Devices and Therapeutics Market Share by Insulin Pens, by Value (UDS MM) 2018-2027 Figure 18: United Kingdom Diabetes Devices and Therapeutics Market Share by Insulin Syringes, by Value (UDS MM) 2018-2027 Figure 19: United Kingdom Diabetes Devices and Therapeutics Market Share by Therapeutics (%), 2018-2027 Figure 20: United Kingdom Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, by Value (USD MM), 2018-2027 Figure 21: United Kingdom Diabetes Devices and Therapeutics Market Size by Insulin, by Value (USD MM), 2018-2027 Figure 22: United Kingdom Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, by Value (USD MM), 2018-2027 Figure 23: United Kingdom Diabetes Devices and Therapeutics Market Size by Combination Drugs, by Value (USD MM), 2018-2027 Figure 24: United Kingdom Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs (%), 2018-2027 Figure 25: United Kingdom Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors (USD MM), 2018-2027 Figure 26: United Kingdom Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors (USD MM), 2018-2027 Figure 27: United Kingdom Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors (USD MM), 2018-2027 Figure 28: United Kingdom Diabetes Devices and Therapeutics Market Share by Insulin (%), 2018-2027 Figure 29: United Kingdom Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, by Value (USD MM), 2018-2027 Figure 30: United Kingdom Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, by Value (USD MM), 2018-2027 Figure 31: United Kingdom Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, by Value (USD MM), 2018-2027 Figure 32: United Kingdom Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, by Value (USD MM), 2018-2027 Figure 33: United Kingdom Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs (%), 2018-2027 Figure 34: United Kingdom Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, by Value (USD MM), 2018-2027 Figure 35: United Kingdom Diabetes Devices and Therapeutics Market Size by Amylin Analogue, by Value (USD MM), 2018-2027 Figure 36: United Kingdom Diabetes Devices and Therapeutics Market Share by Combination Drugs (%), 2018-2027 Figure 37: United Kingdom Diabetes Devices and Therapeutics Market Size by Combination Insulin, by Value (USD MM), 2018-2027 Figure 38: United Kingdom Diabetes Devices and Therapeutics Market Size by Oral Combination, by Value (USD MM), 2018-2027 Figure 39: United Kingdom Diabetes Devices and Therapeutics Market Share by Route of Administration (%), 2018-2027 Figure 40: United Kingdom Diabetes Devices and Therapeutics Market Size by Subcutaneous, by Value (USD MM), 2018-2027 Figure 41: United Kingdom Diabetes Devices and Therapeutics Market Size by Intravenous, by Value (USD MM), 2018-2027 Figure 42: United Kingdom Diabetes Devices and Therapeutics Market Size by Others, by Value (USD MM), 2018-2027 Figure 43: United Kingdom Diabetes Devices and Therapeutics Market Share by Type of Diabetes (%), 2018-2027 Figure 44: United Kingdom Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, by Value (USD MM), 2018-2027 Figure 45: United Kingdom Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, by Value (USD MM), 2018-2027 Figure 46: United Kingdom Diabetes Devices and Therapeutics Market Share by Distribution Channels (%), 2018-2027 Figure 47: United Kingdom Diabetes Devices and Therapeutics Market Size by Online Pharmacies, by Value (USD MM), 2018-2027 Figure 48: United Kingdom Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, by Value (USD MM), 2018-2027 Figure 49: United Kingdom Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, by Value (USD MM), 2018-2027 Figure 50: United Kingdom Diabetes Devices and Therapeutics Market Share by End User (%), 2018-2027 Figure 51: United Kingdom Diabetes Devices and Therapeutics Market Size by Hospitals, by Value (USD MM), 2018-2027 Figure 52: United Kingdom Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, by Value (USD MM), 2018-2027 Figure 53: United Kingdom Diabetes Devices and Therapeutics Market Size by Homecare, by Value (USD MM), 2018-2027
